---
schema_version: "secwatch.filing_event.v1"
accession: "0000927066-22-000075"
form_type: "8-K"
ticker: "DVA"
cik: "0000927066"
company_name: "DAVITA INC."
filed_at: "2022-05-05T23:59:59+00:00"
generated_at: "2026-06-26T00:15:56.941123+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# DaVita Q1 2022 EPS $1.61, down 10% from prior quarter; revenue $2.818B

## Summary
- Diluted EPS of $1.61 vs $1.79 in Q4 2021 and $2.09 in Q1 2021; adjusted EPS $1.61.
- Consolidated revenue of $2.818 billion for the quarter.
- Operating income of $338 million; operating cash flow $322 million, free cash flow $147 million.
- Repurchased 2.1 million shares at avg cost $110.90 per share.
- COVID-19 Omicron variant caused higher patient mortality and missed treatments, plus wage inflation.

## SEC filing metadata
- accession: 0000927066-22-000075
- form_type: 8-K
- ticker: DVA
- cik: 0000927066
- company_name: DAVITA INC.
- filed_at: 2022-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/927066/000092706622000075/0000927066-22-000075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/927066/000092706622000075/dva-20220505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000927066-22-000075
- JSON: https://secwatch.observer/filing/0000927066-22-000075.json
- Plain text: https://secwatch.observer/filing/0000927066-22-000075.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.